Shanghai Chest Hospital
261
54
68
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
5 terminated/withdrawn out of 261 trials
88.1%
+1.6% vs industry average
11%
29 trials in Phase 3/4
3%
1 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (261)
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Role: lead
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
Role: lead
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
Role: collaborator
Renal Denervation Combined With Pulsed Field Ablation to Prevent Recurrence in Persistent Atrial Fibrillation
Role: lead
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Role: lead
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
Role: collaborator
Infiltration Pattern of Locally Advanced ESCC
Role: lead
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
Role: lead
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Role: lead
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
Role: collaborator
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC
Role: lead
Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules
Role: lead
PRL3-Zumab in Patients With Advanced Solid Tumors
Role: collaborator
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
Role: lead
Shanghai Clinical Cohort - Esophageal Cancer
Role: lead
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Role: lead
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
Role: lead
Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
Role: lead
RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs
Role: lead
A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
Role: collaborator